Predefined Single-Use Production Platforms for Biomanufacturing
The biopharmaceutical industry can reduce the time and cost required to bring products to the clinic and the market by taking advantage of single-use production platforms. These platforms integrate proven services and technologies for the development and manufacture of mAbs, vaccines and bioconjugates.
Companies can streamline early stage process development activities by leveraging the expertise and experience Sartorius has acquired over many years while establishing biomanufacturing processes for clients. Furthermore, Sartorius can expedite the engineering of single-use and hybrid processes for scale-up during late stage activities using process templates that reduce design costs and increase standardization.
Sartorius Biomanufacturing Platforms
Reduce Time-To-Market & Cost with Single-Use Platforms